Picture of Biorestorative Therapies logo

BRTX — Biorestorative Therapies News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: BioRestorative Therapies Got Unanimous Recommendation To Proceed Phase 2 Trial For Chronic Lumbar Disc Disease, BRTX-100

July 7 (Reuters) - BioRestorative Therapies Inc
 BRTX.O :
    * BIORESTORATIVE THERAPIES - GOT UNANIMOUS RECOMMENDATION TO
PROCEED PHASE 2 TRIAL FOR CHRONIC LUMBAR DISC DISEASE, BRTX-100
    * BIORESTORATIVE THERAPIES -THERE WERE NO SEVERE ADVERSE
EVENTS
THAT WERE CORRELATED TO DOSE LIMITING TOXICITY( DLTS)

Further company coverage:  BRTX.O 

 (Reuters.Briefs@thomsonreuters.com)

Recent news on Biorestorative Therapies

See all news